News

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...
The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.
Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...
Earwax tests could help with early Parkinson’s detection, Chinese researchers discover, offering hope for improved diagnosis ...
Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...
A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...
Common cough medicine revealed to slow down Parkinson's disease and dementia - A 12-month study found that Ambroxol helped ...
Okemos, Mich. (WILX) - Kirk Gibson recently turned 68, and for the past 10 years he has battled the effects of Parkinson’s ...
A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.
Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic ...
Elizabeth Jonas first got interested in mitochondria by chance. In 1995, she was a postdoctoral researcher at Yale, working ...
Parkinson’s disease diagnoses are rising across East Africa—hinting at a shift in healthcare priorities. Frank Burkybile reports One sunny afternoon in Nairobi a crowd of 200 patients, care givers, ...